High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities

Background Joint pain is a common symptom in patients with hypermobile Ehlers-Danlos Syndrome (hEDS), hypermobility spectrum disorders (HSD) and fibromyalgia. The goal of this study was to determine whether symptoms and comorbidities overlap in patients diagnosed with hEDS/HSD and/or fibromyalgia. Methods We retrospectively examined self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS/HSD, fibromyalgia, or both vs. controls with an emphasis on joint issues. Results From 733 patients seen at the EDS Clinic, 56.5% (n = 414) were diagnosed with hEDS/HSD and fibromyalgia (Fibro), 23.8% (n = 167) hEDS/HSD, 13.3% (n = 98) fibromyalgia, or 7.4% (n = 54) none of these diagnoses. More patients were diagnosed with HSD (76.6%) than hEDS (23.4%). Patients were primarily White (95%) and female (90%) with a median age in their 30s (controls 36.7 [18.0, 70.0], fibromyalgia 39.7 [18.0, 75.0], hEDS/HSD 35.0 [18.0, 71.0], hEDS/HSD&Fibro 31.0 [18.0, 63.0]). There was high overlap in all 40 symptoms/comorbidities that we examined in patients diagnosed with fibromyalgia only or hEDS/HSD&Fibro, regardless of whether they had hEDS or HSD. Patients that only had hEDS/HSD without fibromyalgia had far fewer symptoms/comorbidities than patients with hEDS/HSD&Fibro. The top self-reported issues in patients that only had fibromyalgia were joint pain, hand pain when writing or typing, brain fog, joint pain keeping from daily activities, allergy/atopy and headache. Five issues that significantly and uniquely characterized patients diagnosed with hEDS/HSD&Fibro were subluxations (dislocations in hEDS patients), joint issues like sprains, the need to stop sports due to injuries, poor wound healing, and migraine. Conclusion The majority of patients seen at the EDS Clinic had a diagnosis of hEDS/HSD plus fibromyalgia that was associated with more severe disease. Our findings indicate that fibromyalgia should be routinely assessed in patients with hEDS/HSD and vis-a-versa to improve patient care.

[1]  Delaram Nourmohammadi,et al.  Immunologic aspects of migraine: A review of literature , 2022, Frontiers in Neurology.

[2]  A. Priori,et al.  Hypermobile spectrum disorders symptoms in patients with functional neurological disorders and autism spectrum disorders: A preliminary study , 2022, Frontiers in Psychiatry.

[3]  Elaine Meade,et al.  The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy , 2022, International journal of molecular sciences.

[4]  T. Rozen,et al.  Establishing an Ehlers-Danlos Syndrome Clinic: Lessons Learned , 2022, SN Comprehensive Clinical Medicine.

[5]  Y. Okayama,et al.  Neuro-allergology: Mast cell-nerve cross-talk. , 2022, Allergology international : official journal of the Japanese Society of Allergology.

[6]  R. Cui,et al.  Sex Differences in Depression Caused by Early Life Stress and Related Mechanisms , 2022, Frontiers in Neuroscience.

[7]  M. Humble,et al.  The Relationship Between Generalised Joint Hypermobility and Autism Spectrum Disorder in Adults: A Large, Cross-Sectional, Case Control Comparison , 2022, Frontiers in Psychiatry.

[8]  T. O. Olde Hartman,et al.  Stigma perceived by patients with functional somatic syndromes and its effect on health outcomes - A systematic review. , 2022, Journal of psychosomatic research.

[9]  D. Kaelber,et al.  Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders , 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  R. Knez,et al.  Prevalence of ADHD and Autism Spectrum Disorder in Children with Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study , 2021, Neuropsychiatric disease and treatment.

[11]  A. Michos,et al.  Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2020, Frontiers in Neurology.

[12]  G. Cruccu,et al.  Pain due to Ehlers-Danlos Syndrome Is Associated with Deficit of the Endogenous Pain Inhibitory Control. , 2020, Pain medicine.

[13]  H. Critchley,et al.  BEYOND BONES - THE RELEVANCE OF VARIANTS OF CONNECTIVE TISSUE (HYPERMOBILITY) TO FIBROMYALGIA, ME/CFS AND CONTROVERSIES SURROUNDING DIAGNOSTIC CLASSIFICATION: AN OBSERVATIONAL STUDY , 2020, medRxiv.

[14]  T. Theoharides,et al.  Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome , 2019, Front. Cell. Neurosci..

[15]  G. Littlejohn,et al.  Faculty Opinions recommendation of 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[16]  R. Thangavel,et al.  Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer’s Disease , 2019, Front. Cell. Neurosci..

[17]  P. S. Santa Maria,et al.  A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms , 2019, Clinical Reviews in Allergy & Immunology.

[18]  C. Friesen,et al.  An observational study of headaches in children and adolescents with functional abdominal pain , 2018, Medicine.

[19]  L. Qiu,et al.  A preliminary study , 2018, Medicine.

[20]  J. Parisi,et al.  Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome. , 2018, American journal of human genetics.

[21]  L. Rombaut,et al.  Hypermobility, the Ehlers-Danlos syndromes and chronic pain. , 2017, Clinical and experimental rheumatology.

[22]  C. Graver.  Functional Somatic Syndrome: Assessment and Management , 2017, The Journal of the American Osteopathic Association.

[23]  A. Larsson,et al.  Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma , 2017, Journal of pain research.

[24]  R. Grahame,et al.  Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[25]  J. Belmont,et al.  The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[26]  R. Engelbert,et al.  Disability in Adolescents and Adults Diagnosed With Hypermobility-Related Disorders: A Meta-Analysis. , 2016, Archives of physical medicine and rehabilitation.

[27]  Philip J Mease,et al.  2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.

[28]  R. Baron,et al.  Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type , 2016, European journal of pain.

[29]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[30]  T. Rozen.  Triggering Events and New Daily Persistent Headache: Age and Gender Differences and Insights on Pathogenesis–A Clinic‐Based Study , 2016, Headache.

[31]  G. Pailhez,et al.  Emotion processing in joint hypermobility: A potential link to the neural bases of anxiety and related somatic symptoms in collagen anomalies , 2015, European Psychiatry.

[32]  G. Verreck,et al.  Preclinical and Clinical Studies , 2015 .

[33]  Daniel J Clauw,et al.  Fibromyalgia: a clinical review. , 2014, JAMA.

[34]  F. Wolfe,et al.  Prevalence of Fibromyalgia: A Population‐Based Study in Olmsted County, Minnesota, Utilizing the Rochester Epidemiology Project , 2013, Arthritis care & research.

[35]  J. Seo,et al.  Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia , 2013, Cephalalgia : an international journal of headache.

[36]  D. Clauw,et al.  Central pain mechanisms in the rheumatic diseases: future directions. , 2013, Arthritis and rheumatism.

[37]  W. Mitzner,et al.  Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. , 2012, American journal of physiology. Heart and circulatory physiology.

[38]  M. Castori,et al.  Chronic fatigue syndrome is commonly diagnosed in patients with Ehlers-Danlos syndrome hypermobility type/joint hypermobility syndrome. , 2011, Clinical and experimental rheumatology.

[39]  J. Croft,et al.  Cumulative Childhood Stress and Autoimmune Diseases in Adults , 2009, Psychosomatic medicine.

[40]  P. Sarzi-Puttini,et al.  Etiology of fibromyalgia: the possible role of infection and vaccination. , 2008, Autoimmunity reviews.

[41]  P. Sullivan,et al.  A population-based twin study of functional somatic syndromes , 2008, Psychological Medicine.

[42]  D. Fairweather,et al.  Mast cells and inflammatory heart disease: potential drug targets. , 2008, Cardiovascular & hematological disorders drug targets.

[43]  F. Schmidt.  Meta-Analysis , 2008 .

[44]  John McBeth,et al.  Epidemiology of chronic musculoskeletal pain. , 2007, Best practice & research. Clinical rheumatology.

[45]  O. Şendur,et al.  The frequency of hypermobility and its relationship with clinical findings of fibromyalgia patients , 2007, Clinical Rheumatology.

[46]  Walter S. DeKeseredy.  Future Directions , 2006, Violence against women.

[47]  TD Rozen,et al.  Cervical Spine Joint Hypermobility: A Possible Predisposing Factor for New Daily Persistent Headache , 2006, Cephalalgia : an international journal of headache.

[48]  E. Silbergeld,et al.  Cutting Edge: T Cell Ig Mucin-3 Reduces Inflammatory Heart Disease by Increasing CTLA-4 during Innate Immunity1 , 2006, The Journal of Immunology.

[49]  D. Ofluoğlu,et al.  Hypermobility in women with fibromyalgia syndrome , 2006, Clinical Rheumatology.

[50]  P. Keck,et al.  Family study of fibromyalgia. , 2004, Arthritis and rheumatism.

[51]  C. Nemeroff,et al.  The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies , 2001, Biological Psychiatry.

[52]  R. Bennett,et al.  A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. , 1997, Arthritis and rheumatism.

[53]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[54]  B. Fischer.  Lessons Learned. , 2016, Schizophrenia bulletin.

[55]  Susan Abbey,et al.  COPYRIGHT PULSUS GROUP INC. – DO NOT COPY , 2013 .

[56]  Jeffrey D. Lewis,et al.  Central sensitization as a component of post-deployment syndrome. , 2012, NeuroRehabilitation.

[57]  Antonio Pflüger,et al.  Executive Summary. , 2012, Journal of the ICRU.

[58]  Richard E. Harris,et al.  Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. , 2011, The journal of pain : official journal of the American Pain Society.

[59]  A. R.,et al.  Review of literature , 1969, American Potato Journal.

[60]  G. Jensen,et al.  Assessment and management , 1998 .